- This event has passed.
Innovating Technologies for Broader and Safer Redirected T-cell Therapies of Cancer
December 8, 2017 @ 11:00 am - 12:00 pm
Cheng Liu, PhD Founder & CEO Eureka Therapeutics, San Francisco Bay Area 1022 LS
Nature – Pathogens- Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters May 18, 2024
- Enhanced CD95 and interleukin 18 signalling accompany T cell receptor Vβ21.3+ activation in multi-inflammatory syndrome in children May 18, 2024
- Spatial disparities in the mortality burden of the covid-19 pandemic across 569 European regions (2020-2021) May 18, 2024
- Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China May 18, 2024
- Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium May 18, 2024
- Nature – AMR
- Generation and maintenance of the circularized multimeric IS26-associated translocatable unit encoding multidrug resistance May 18, 2024
- Genomic insights unveil the plasmid transfer mechanism and epidemiology of hypervirulent Klebsiella pneumoniae in Vietnam May 17, 2024
- Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapy May 16, 2024
- Lipase-mediated detoxification of host-derived antimicrobial fatty acids by Staphylococcus aureus May 15, 2024
- Modelling the impact of wastewater flows and management practices on antimicrobial resistance in dairy farms May 14, 2024
- Outbreaks
- Measles global outbreak continues to spread April 16, 2024
- Dad goes Viral on TikTok: Daughter has Pinworms April 16, 2024
- CDC
- Food Safety News
- Cryptosporidium outbreak affects dozens in England May 19, 2024
- University of Maryland professor named 2024 IFT Fellow May 18, 2024